New microscope offers options for drug discovery, safety
Researchers have developed a microscope that may provide insight into how safely and effectively a drug will perform in the body...
List view / Grid view
Researchers have developed a microscope that may provide insight into how safely and effectively a drug will perform in the body...
A New Drug Application has been made to the US Food and Drug Administration for the drug darolutamide to treat non-metastatic prostate cancer...
Researchers have developed a highly sensitive, mechanical needle that targets tissue reliably and precisely for the delivery of therapeutics...
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases...
Gore, a global materials science company, attends Pharmapack Europe to continue their year-long launch of the GORE™ ImproJect™ Plunger for pre-filled syringes...
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest whitepaper...
General Electric is selling its biopharma business for $21.4 billion, with shares in the company jumping 16 percent upon the news...
The European Medicines Agency (EMA) has lost a High Court case, meaning it will have to pay the remaining 20 years left on the lease...
US researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data using blockchain...
A method commonly used in lithium-ion batteries has been developed to help the safer and cheaper manufacture of medicines...
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...